Bioinformatic analysis highlights SNHG6 as a putative prognostic biomarker for kidney renal papillary cell carcinoma

Abstract Purpose Kidney renal papillary cell carcinoma (KIRP) is a highly heterogeneous malignancy and current systemic therapeutic strategies are difficult to achieve a satisfactory outcome for advanced disease. Meanwhile, there is a lack of effective biomarkers to predict the prognosis of KIRP. Me...

Full description

Bibliographic Details
Main Authors: Yifu Liu, Xiaofeng Cheng, Ping Xi, Zhicheng Zhang, Ting Sun, Binbin Gong
Format: Article
Language:English
Published: BMC 2023-04-01
Series:BMC Urology
Subjects:
Online Access:https://doi.org/10.1186/s12894-023-01218-5
_version_ 1797853530528153600
author Yifu Liu
Xiaofeng Cheng
Ping Xi
Zhicheng Zhang
Ting Sun
Binbin Gong
author_facet Yifu Liu
Xiaofeng Cheng
Ping Xi
Zhicheng Zhang
Ting Sun
Binbin Gong
author_sort Yifu Liu
collection DOAJ
description Abstract Purpose Kidney renal papillary cell carcinoma (KIRP) is a highly heterogeneous malignancy and current systemic therapeutic strategies are difficult to achieve a satisfactory outcome for advanced disease. Meanwhile, there is a lack of effective biomarkers to predict the prognosis of KIRP. Methods Using TCGA, GTEx, UALCAN, TIMER, TIMER 2.0 and STRING databases, we analyzed the relationship of SNHG6 with KIRP subtypes, tumor-infiltrating immune cells and potential target mRNAs. Based on TCGA data, ROC curves, Kaplan–Meier survival analysis and COX regression analysis were performed to evaluate the diagnostic and prognostic value of SNHG6 in KIRP. Nomogram was used to predict 3- and 5-year disease-specific survival in KIRP patients. In addition, with the help of Genetic ontology and Gene set enrichment analysis, the biological processes and signalling pathways that SNHG6 may be involved in KIRP were initially explored. Results In patients with KIRP, SNHG6 was significantly upregulated and associated with a more aggressive subtype (lymph node involvement, pathological stage IV, CIMP phenotype) and poor prognosis. The ROC curve showed good diagnostic efficacy (AUC value: 0.828) and the C-index of the Nomogram for predicting DSS at 3 and 5 years was 0.920 (0.898–0.941). In the immune microenvironment of KIRP, SNHG6 expression levels were negatively correlated with macrophage abundance and positively correlated with cancer-associated fibroblasts. Furthermore, SNHG6 may promote KIRP progression by regulating the expression of molecules such as AURKB, NDC80, UBE2C, NUF2, PTTG1, CENPH, SPC25, CDCA3, CENPM, BIRC5, TROAP, EZH2. Last, GSEA suggests that SNHG6 may be involved in the regulation of the PPAR signalling pathway and the SLIT/ROBO signalling pathway. Conclusions Our analysis suggests that a high SNHG6 expression status in KIRP is associated with a poorer prognosis for patients, and also elucidates some potential mechanisms contributing to this poorer outcome. This may provide new insights into the treatment and management of KIRP in the foreseeable future.
first_indexed 2024-04-09T19:52:07Z
format Article
id doaj.art-92543c94a98f416c9ddedd83cbf13e4c
institution Directory Open Access Journal
issn 1471-2490
language English
last_indexed 2024-04-09T19:52:07Z
publishDate 2023-04-01
publisher BMC
record_format Article
series BMC Urology
spelling doaj.art-92543c94a98f416c9ddedd83cbf13e4c2023-04-03T05:42:03ZengBMCBMC Urology1471-24902023-04-0123111310.1186/s12894-023-01218-5Bioinformatic analysis highlights SNHG6 as a putative prognostic biomarker for kidney renal papillary cell carcinomaYifu Liu0Xiaofeng Cheng1Ping Xi2Zhicheng Zhang3Ting Sun4Binbin Gong5Department of Urology, The First Affiliated Hospital of Nanchang UniversityDepartment of Urology, The First Affiliated Hospital of Nanchang UniversityDepartment of Urology, The First Affiliated Hospital of Nanchang UniversityDepartment of Urology, The First Affiliated Hospital of Nanchang UniversityDepartment of Urology, The First Affiliated Hospital of Nanchang UniversityDepartment of Urology, The First Affiliated Hospital of Nanchang UniversityAbstract Purpose Kidney renal papillary cell carcinoma (KIRP) is a highly heterogeneous malignancy and current systemic therapeutic strategies are difficult to achieve a satisfactory outcome for advanced disease. Meanwhile, there is a lack of effective biomarkers to predict the prognosis of KIRP. Methods Using TCGA, GTEx, UALCAN, TIMER, TIMER 2.0 and STRING databases, we analyzed the relationship of SNHG6 with KIRP subtypes, tumor-infiltrating immune cells and potential target mRNAs. Based on TCGA data, ROC curves, Kaplan–Meier survival analysis and COX regression analysis were performed to evaluate the diagnostic and prognostic value of SNHG6 in KIRP. Nomogram was used to predict 3- and 5-year disease-specific survival in KIRP patients. In addition, with the help of Genetic ontology and Gene set enrichment analysis, the biological processes and signalling pathways that SNHG6 may be involved in KIRP were initially explored. Results In patients with KIRP, SNHG6 was significantly upregulated and associated with a more aggressive subtype (lymph node involvement, pathological stage IV, CIMP phenotype) and poor prognosis. The ROC curve showed good diagnostic efficacy (AUC value: 0.828) and the C-index of the Nomogram for predicting DSS at 3 and 5 years was 0.920 (0.898–0.941). In the immune microenvironment of KIRP, SNHG6 expression levels were negatively correlated with macrophage abundance and positively correlated with cancer-associated fibroblasts. Furthermore, SNHG6 may promote KIRP progression by regulating the expression of molecules such as AURKB, NDC80, UBE2C, NUF2, PTTG1, CENPH, SPC25, CDCA3, CENPM, BIRC5, TROAP, EZH2. Last, GSEA suggests that SNHG6 may be involved in the regulation of the PPAR signalling pathway and the SLIT/ROBO signalling pathway. Conclusions Our analysis suggests that a high SNHG6 expression status in KIRP is associated with a poorer prognosis for patients, and also elucidates some potential mechanisms contributing to this poorer outcome. This may provide new insights into the treatment and management of KIRP in the foreseeable future.https://doi.org/10.1186/s12894-023-01218-5Small nucleolar RNA host gene 6Kidney renal papillary cell carcinomaPrognosisBiomarkers
spellingShingle Yifu Liu
Xiaofeng Cheng
Ping Xi
Zhicheng Zhang
Ting Sun
Binbin Gong
Bioinformatic analysis highlights SNHG6 as a putative prognostic biomarker for kidney renal papillary cell carcinoma
BMC Urology
Small nucleolar RNA host gene 6
Kidney renal papillary cell carcinoma
Prognosis
Biomarkers
title Bioinformatic analysis highlights SNHG6 as a putative prognostic biomarker for kidney renal papillary cell carcinoma
title_full Bioinformatic analysis highlights SNHG6 as a putative prognostic biomarker for kidney renal papillary cell carcinoma
title_fullStr Bioinformatic analysis highlights SNHG6 as a putative prognostic biomarker for kidney renal papillary cell carcinoma
title_full_unstemmed Bioinformatic analysis highlights SNHG6 as a putative prognostic biomarker for kidney renal papillary cell carcinoma
title_short Bioinformatic analysis highlights SNHG6 as a putative prognostic biomarker for kidney renal papillary cell carcinoma
title_sort bioinformatic analysis highlights snhg6 as a putative prognostic biomarker for kidney renal papillary cell carcinoma
topic Small nucleolar RNA host gene 6
Kidney renal papillary cell carcinoma
Prognosis
Biomarkers
url https://doi.org/10.1186/s12894-023-01218-5
work_keys_str_mv AT yifuliu bioinformaticanalysishighlightssnhg6asaputativeprognosticbiomarkerforkidneyrenalpapillarycellcarcinoma
AT xiaofengcheng bioinformaticanalysishighlightssnhg6asaputativeprognosticbiomarkerforkidneyrenalpapillarycellcarcinoma
AT pingxi bioinformaticanalysishighlightssnhg6asaputativeprognosticbiomarkerforkidneyrenalpapillarycellcarcinoma
AT zhichengzhang bioinformaticanalysishighlightssnhg6asaputativeprognosticbiomarkerforkidneyrenalpapillarycellcarcinoma
AT tingsun bioinformaticanalysishighlightssnhg6asaputativeprognosticbiomarkerforkidneyrenalpapillarycellcarcinoma
AT binbingong bioinformaticanalysishighlightssnhg6asaputativeprognosticbiomarkerforkidneyrenalpapillarycellcarcinoma